Skip to main content

Advertisement

Table 1 Baseline characteristics of 4 groups

From: High triglyceride–glucose index is associated with poor prognosis in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention

VariableQ1 (n = 273)Q2 (n = 273)Q3 (n = 273)Q4 (n = 273)P value
TyG index8.373 ± 0.2588.905 ± 0.1229.345 ± 0.14510.076 ± 0.483< 0.001
Age, years65.2 ± 13.263.5 ± 10.861.2 ± 11.657.6 ± 12.4< 0.001
Male219 (80.2)220 (80.6)222 (81.3)213 (78.0)0.546
BMI, kg/m225.2 (24.7–25.5)25.5 (25.1–25.8)26.0 (25.6–26.2)26.5 (26.0–26.9)0.012
SBP, mmHg124.9 ± 22.1128.7 ± 21.9129.9 ± 20.8138.3 ± 22.6< 0.001
DBP, mmHg75.2 ± 14.176.6 ± 13.477.1 ± 14.384.7 ± 16.8< 0.001
Heart rate, bpm77.7 ± 14.579.7 ± 13.179.0 ± 12.782.2 ± 16.30.019
Killip class > 182 (30.3)85 (31.1)91 (33.3)89 (32.6)0.523
Smoker114 (41.8)120 (44.0)123 (45.1)126 (46.2)0.886
Hypertension138 (50.5)162 (60.0)177 (64.8)201 (73.6)< 0.001
Diabetes mellitus21 (7.7)45 (16.5)81 (29.7)123 (45.1)< 0.001
Anemia33 (12.1)26 (9.5)30 (11.0)35 (12.8)0.322
Previous AMI6 (2.2)6 (2.2)7 (2.6)8 (2.9)0.489
Atrial fibrillation16 (5.8)13 (4.8)17 (6.2)15 (5.5)0.652
Biochemical indicators
 NT-proBNP, pg/mL (IQR)525.5 (31.0–2193.2)534.4 (53.5–2293.7)527.6 (34.9–2401.4)546 (71.2–2603.2)0.179
 Cardiac troponin I, ng/ml (IQR)12.2 (3.01–22.7)11.6 (2.7–23.1)13.1 (2.3–23.9)12.7 (2.6–24.2)0.762
 hs-CRP, mg/L (IQR)7.9 (5.5–10.4)7.3 (4.4–11.1)6.9 (3.9–9.7)7.3 (3.4–10.7)0.652
 White blood cells, 109/L9.9 ± 3.910.0 ± 3.910.0 ± 3.210.2 ± 3.20.826
 Neutrophil ratio75.5 ± 10.376.2 ± 11.475.2 ± 13.675.9 ± 12.90.775
 Platelet, 109/L195.0 ± 56.1201.8 ± 60.5228.8 ± 63.0223.8 ± 53.9< 0.001
 Albumin, g/L36.1 ± 4.837.3 ± 4.137.6 ± 4.538.2 ± 5.20.022
 FPG, mmol/L6.6 ± 1.97.1 ± 1.88.1 ± 2.411.7 ± 6.0< 0.001
 Measured HbA1c,  % (IQR)6.5 (6.2–6.8)7.1 (6.9–7.4)7.6 (7.5–7.8)8.0 (7.9–8.2)< 0.001
 TC, mmol/L4.0 ± 0.94.3 ± 1.04.8 ± 1.25.2 ± 1.3< 0.001
 Triglycerides, mmol/L0.9 ± 0.31.4 ± 0.31.9 ± 0.63.6 ± 2.6< 0.001
 HDL-C, mmol/L1.0 ± 0.31.1 ± 0.21.2 ± 0.31.2 ± 0.3< 0.001
 LDL-C, mmol/L2.4 ± 0.72.7 ± 0.83.0 ± 1.03.1 ± 0.8< 0.001
 Uric acid, umol/L319.5 ± 102.6325.5 ± 87.3342.2 ± 109.3347.4 ± 100.60.019
 eGFR, mL/min87.0 ± 32.885.4 ± 42.086.9 ± 34.389.5 ± 39.10.423
Coronary angiography
 GPIIb/IIIa antagonists91 (33.3)89 (32.6)86 (31.8)92 (33.7)0.644
 Anticoagulation25 (9.2)27 (9.9)22 (8.1)24 (8.8)0.546
 Lesion vessels3.2 ± 1.63.2 ± 1.53.0 ± 1.83.1 ± 1.30.743
 Three-vessel disease105 (38.5)138 (50.5)150 (54.9)168 (61.5)< 0.001
 Number of stents1.03 ± 0.541.02 ± 0.471.02 ± 0.451.11 ± 0.500.114
 Gensini score, (IQR)61.6 (49.3–75.7)65.4 (54.1–72.6)71.6 (60.9–79.3)78.3 (63.1–83.9)0.049
Echocardiography
 LVEF0.55 ± 0.120.54 ± 0.100.56 ± 0.100.55 ± 0.120.335
Medications use at discharge
 Aspirin255 (93.4)264 (96.7)264 (96.7)267 (97.8)0.059
 Clopidogrel/Ticagrelor267 (97.8)270 (98.9)267 (97.8)273 (100)0.082
 Statin261 (95.6)265 (97.1)267 (97.8)260 (95.2)0.321
 Beta blockers215 (78.8)228 (83.5)210 (76.4)223 (81.1)0.247
 ACEI/ARB168 (61.1)180 (65.5)171 (62.2)183 (66.5)0.205
  1. Data are presented as the IQR, mean ± SD or n (%)
  2. BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, AMI acute myocardial infarction, IQR interquartile range, hs-CRP hypersensitive C-reactive protein, FPG fasting plasma glucose, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, SCr Serum creatinine concentration, eGFR estimated glomerular filtration rate, LVEF left ventricular ejection fraction